Site Metrics and Web Analytics by WebSTAT
Home Orafate™ D9630

In-Office Procedure
Using Orafate™ About Orafate™ FAQs Healthcare Professionals Contact us
Urgent Care for aphthous ulcers, cold sores and dry sockets

Orafate™ (polymerized and cross-linked sucralfate) is associated with rapid healing and treatment of
canker sores (aphthous ulcers), cold sores (herpes labialis) and dry sockets (alveolar osteitis)


Orafate™ is a new post-surgical treatment for oral wounds

Orafate™ is FDA-cleared and addresses the unmet dental needs caused by mild to moderate
gingivitis, dental procedure wounds, post-op surgical wounds and severe periodontitis


Orafate™ accelerates the healing while reducing the pain

Orafate™ can be used by ENT surgeons to effectively accelerate the healing of
post-op surgical wounds of tonsillectomies and uvuloplasty


Urgent Care for aphthous ulcers, cold sores and dry sockets

Orafate™ (polymerized and cross-linked sucralfate) is associated with rapid healing and treatment of
canker sores (aphthous ulcers), cold sores (herpes labialis) and dry sockets (alveolar osteitis)




Special Interest Sites
American Dental Association
		
American Association of Orthodontists
		
American Academy of Otolaryngologists
		
American Academy of Periodontists
		
Related Events
  -	 American Academy of Otolaryngologists
	(AAO) HNSF Annual Meeting & OTO Expo
	September 21-24 2014
	
  -    American Dental Association Annual  
	meeting. October 9-14 2014
	San Antonio
	
  -	 American Academy of Periodontologists 
	Annual meeting  (100th Anniversary)
	September 19-22 2014 San Francisco
	
  -	 American Association of Orthodontists 
	2015 Winter Conference 
	February 06-08. Miami FL
	
  -	 American Association of Orthodontists 
	2015 Annual Session 
	May 15-19. San Francisco 
	
The Orafate™ Program
 	In-Office Orafate Procedures and
	Out-of-Office Prescription	
	
	Orafate™, a new FDA prescription 
	oral wound medical device, 
	containing enhanced potency 
	sucralfate, is being launched for 
	use as a reimbursable in-office 
	procedure, following all 
	cleanings and all extractions, 
	reimbursable under ADA procedure 
	code D9630.  [Learn More]
		
News and Press Releases
  -	What the Reduction in Tonsillectomies 
	teaches us about Medicine
	
  -    The cause of gum disease is related to 
	type two diabetes
	
  -	 On the link between periodontitis and 
	atherosclerosis
	
	[Click for More news]
Patient Information
	Orafate™ is a patented high potency 
	reformulation of sucralfate used for 
	the management of oral wounds and 
	inflammation. The clinical effects of 
	Orafate™ is conveyed solely 
	through its physical contact with the 
	inflamed, injured or ulcerated lining. 
	
	Orafate™ should be used 3 times daily 
	for the 1st day then twice daily for 
	1 week or as directed by the dentist 
	or healthcare provider. [Read more]
		
Prescribe Orafate™
          Copyright© Mueller Medical International LLC 2014. All rights reserved.